Literature DB >> 22727961

Antiplatelet effect of 600- and 300-mg loading doses of clopidogrel in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an analysis of the ARMYDA-6 MI (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Myocardial Infarction) Study.

Fabio Mangiacapra1, Giuseppe Patti, Emanuele Barbato, Dejan Orlic, Aaron J Peace, Andrea D'Ambrosio, Miodrag Ostojic, William Wijns, Germano Di Sciascio.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22727961     DOI： 10.1016/j.ijcard.2012.06.015

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  2 in total

1.  Cost-effectiveness of clopidogrel, prasugrel and ticagrelor for dual antiplatelet therapy after acute coronary syndrome: a decision-analytic model.

Authors:  Husam Abdel-Qadir; Idan Roifman; Harindra C Wijeysundera
Journal:  CMAJ Open       Date:  2015-12-09

Review 2.  Reappraisal of thienopyridine pretreatment in patients with non-ST elevation acute coronary syndrome: a systematic review and meta-analysis.

Authors:  Anne Bellemain-Appaix; Mathieu Kerneis; Stephen A O'Connor; Johanne Silvain; Michel Cucherat; Farzin Beygui; Olivier Barthélémy; Jean-Philippe Collet; Laurent Jacq; François Bernasconi; Gilles Montalescot
Journal:  BMJ       Date:  2014-10-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.